Retinopathy of Prematurity Clinical Trials

20 recruitingLast updated: May 13, 2026

There are 20 actively recruiting retinopathy of prematurity clinical trials across 28 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Ankara, Turkey (Türkiye), Paris, France, Durham, North Carolina, United States. Updated daily from ClinicalTrials.gov.


Retinopathy of Prematurity Trials at a Glance

20 actively recruiting trials for retinopathy of prematurity are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Ankara, Paris, and Durham. Lead sponsors running retinopathy of prematurity studies include Bayer, Baskent University Ankara Hospital, and Duke University.

Browse retinopathy of prematurity trials by phase

Treatments under study

About Retinopathy of Prematurity Clinical Trials

Looking for clinical trials for Retinopathy of Prematurity? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Retinopathy of Prematurity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Retinopathy of Prematurity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Phase 2

Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

Retinopathy of Prematurity
University of Zurich276 enrolled3 locationsNCT03083431
Recruiting
Phase 1

Safety, PK and PD of FLQ-101 in Premature Neonates

Retinopathy of Prematurity (ROP)
FELIQS INC.18 enrolled1 locationNCT07093255
Recruiting

An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

Preterm infantsRetinopathy of Prematurity
Bayer200 enrolled1 locationNCT06315556
Recruiting

A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)

Retinopathy of PrematurityInfantsNewborns
Bayer75 enrolled1 locationNCT05705258
Recruiting
Phase 2

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

Intraventricular hemorrhageChronic lung disease of prematurityBronchopulmonary Dysplasia+1 more
OHB Neonatology Ltd.338 enrolled66 locationsNCT03253263
Recruiting
Not Applicable

Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)

Retinopathy of Prematurity
Duke University236 enrolled2 locationsNCT04995341
Recruiting

Imaging Retinal Vasculature in Infant Eyes

Retinopathy of Prematurity
Duke University16 enrolled2 locationsNCT05558059
Recruiting

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

Retinopathy of Prematurity (ROP)ROP Examination
Vanderbilt University Medical Center90 enrolled1 locationNCT06612541
Recruiting
Not Applicable

Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy

Retinopathy of Prematurity (ROP)
Wang Yusheng146 enrolled3 locationsNCT06717412
Recruiting
Phase 3

Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity

Retinopathy of PrematurityDexmedetomidine
Assaf-Harofeh Medical Center30 enrolled1 locationNCT06067958
Recruiting
Not Applicable

The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination

Retinopathy of Prematurity (ROP)
Sinem Basdemir84 enrolled1 locationNCT06694103
Recruiting
Not Applicable

Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study

Necrotizing EnterocolitisRetinopathy of PrematurityBreast Feeding+2 more
Baskent University Ankara Hospital120 enrolled1 locationNCT06672913
Recruiting

Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.

Retinopathy of Prematurity
Baskent University Ankara Hospital1,000 enrolled1 locationNCT06265363
Recruiting
Phase 2Phase 3

Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

Retinopathy of Prematurity
Asociación para Evitar la Ceguera en México1 locationNCT00346814
Recruiting
Phase 4

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

Retinal DiseaseRetinal Vascular DisorderRetinopathy of Prematurity Both Eyes+6 more
Chang Gung Memorial Hospital60 enrolled1 locationNCT06520410
Recruiting
Phase 1

Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants

Retinopathy of Prematurity
Region Skane15 enrolled2 locationsNCT05387941
Recruiting

European Disease Registry on Retinopathy of Prematurity (ROP)

Retinopathy of Prematurity
University Medicine Greifswald3,000 enrolled59 locationsNCT04939571
Recruiting

Clinical and Genetic Analysis of ROP

Retinopathy of Prematurity
Oregon Health and Science University2,000 enrolled5 locationsNCT04420156
Recruiting

Does washing blood for transfusion make a difference to preterm babies?

Necrotizing EnterocolitisRetinopathy of PrematurityIntraventricular Haemorrhage+1 more
South Australian Health and Medical Reseach Institute1,214 enrolled6 locationsACTRN12620000530921
Recruiting

Studying the effect of retinopathy of prematurity screening on cerebral and gut regional oxygenation.

Retinopathy of PrematurityPrematurity
University of Otago30 enrolled1 locationACTRN12618000773235